934 related articles for article (PubMed ID: 18703664)
1. Immune properties of human umbilical cord Wharton's jelly-derived cells.
Weiss ML; Anderson C; Medicetty S; Seshareddy KB; Weiss RJ; VanderWerff I; Troyer D; McIntosh KR
Stem Cells; 2008 Nov; 26(11):2865-74. PubMed ID: 18703664
[TBL] [Abstract][Full Text] [Related]
2. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease.
Weiss ML; Medicetty S; Bledsoe AR; Rachakatla RS; Choi M; Merchav S; Luo Y; Rao MS; Velagaleti G; Troyer D
Stem Cells; 2006 Mar; 24(3):781-92. PubMed ID: 16223852
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cells.
Zhang YN; Lie PC; Wei X
Cytotherapy; 2009; 11(5):548-58. PubMed ID: 19657806
[TBL] [Abstract][Full Text] [Related]
4. Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells.
Ma L; Feng XY; Cui BL; Law F; Jiang XW; Yang LY; Xie QD; Huang TH
Chin Med J (Engl); 2005 Dec; 118(23):1987-93. PubMed ID: 16336835
[TBL] [Abstract][Full Text] [Related]
5. Immune characterization of mesenchymal stem cells in human umbilical cord Wharton's jelly and derived cartilage cells.
Liu S; Yuan M; Hou K; Zhang L; Zheng X; Zhao B; Sui X; Xu W; Lu S; Guo Q
Cell Immunol; 2012; 278(1-2):35-44. PubMed ID: 23121974
[TBL] [Abstract][Full Text] [Related]
6. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.
Tse WT; Pendleton JD; Beyer WM; Egalka MC; Guinan EC
Transplantation; 2003 Feb; 75(3):389-97. PubMed ID: 12589164
[TBL] [Abstract][Full Text] [Related]
7. Immunological properties of umbilical cord blood-derived mesenchymal stromal cells.
Oh W; Kim DS; Yang YS; Lee JK
Cell Immunol; 2008 Feb; 251(2):116-23. PubMed ID: 18495100
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
Nasef A; Mathieu N; Chapel A; Frick J; François S; Mazurier C; Boutarfa A; Bouchet S; Gorin NC; Thierry D; Fouillard L
Transplantation; 2007 Jul; 84(2):231-7. PubMed ID: 17667815
[TBL] [Abstract][Full Text] [Related]
9. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.
Chen MY; Lie PC; Li ZL; Wei X
Exp Hematol; 2009 May; 37(5):629-40. PubMed ID: 19375653
[TBL] [Abstract][Full Text] [Related]
10. The immunobiological development of human bone marrow mesenchymal stem cells in the course of neuronal differentiation.
Liu CT; Yang YJ; Yin F; Wang X; Yu XH; Wang QH; Wang XL; Xie M
Cell Immunol; 2006 Nov; 244(1):19-32. PubMed ID: 17448455
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of human umbilical cord mesenchymal stromal cells into low immunogenic hepatocyte-like cells.
Zhao Q; Ren H; Li X; Chen Z; Zhang X; Gong W; Liu Y; Pang T; Han ZC
Cytotherapy; 2009; 11(4):414-26. PubMed ID: 19513901
[TBL] [Abstract][Full Text] [Related]
12. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
[TBL] [Abstract][Full Text] [Related]
13. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression.
Klyushnenkova E; Mosca JD; Zernetkina V; Majumdar MK; Beggs KJ; Simonetti DW; Deans RJ; McIntosh KR
J Biomed Sci; 2005; 12(1):47-57. PubMed ID: 15864738
[TBL] [Abstract][Full Text] [Related]
14. CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential.
Conconi MT; Burra P; Di Liddo R; Calore C; Turetta M; Bellini S; Bo P; Nussdorfer GG; Parnigotto PP
Int J Mol Med; 2006 Dec; 18(6):1089-96. PubMed ID: 17089012
[TBL] [Abstract][Full Text] [Related]
15. Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities.
Magatti M; De Munari S; Vertua E; Gibelli L; Wengler GS; Parolini O
Stem Cells; 2008 Jan; 26(1):182-92. PubMed ID: 17901399
[TBL] [Abstract][Full Text] [Related]
16. Effects of demineralized bone matrix on proliferation and osteogenic differentiation of mesenchymal stem cells from human umbilical cord.
Honsawek S; Dhitiseith D; Phupong V
J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S189-95. PubMed ID: 17718287
[TBL] [Abstract][Full Text] [Related]
17. Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression.
Nasef A; Mazurier C; Bouchet S; François S; Chapel A; Thierry D; Gorin NC; Fouillard L
Cell Immunol; 2008; 253(1-2):16-22. PubMed ID: 18639869
[TBL] [Abstract][Full Text] [Related]
18. Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton's jelly stem cells.
Fong CY; Subramanian A; Biswas A; Gauthaman K; Srikanth P; Hande MP; Bongso A
Reprod Biomed Online; 2010 Sep; 21(3):391-401. PubMed ID: 20638335
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium.
Wang P; Liu Z; Wu C; Zhu B; Wang Y; Xu H
Transplant Proc; 2008 Oct; 40(8):2729-33. PubMed ID: 18929847
[TBL] [Abstract][Full Text] [Related]
20. A study of the immune properties of human umbilical cord lining epithelial cells.
Cai YJ; Huang L; Leung TY; Burd A
Cytotherapy; 2014 May; 16(5):631-9. PubMed ID: 24364910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
